Insulin-dependent diabetes mellitus (IDDM) is an autoimmune disease characterized by the destruction of the insulin-secreting P cells found in the islets of Langerhans. Reduced P-cell mass results in overt diabetes, requiring lifelong exogenous insulin administration and the possibility of numerous sequelae. Incidence and development of IDDM depend upon a variety of genetic and nongenetic factors. Environmental factors such as chemicals, diet, and infection are suspected to influence the development of disease. This review describes the work performed to date to elucidate the role of these environmental factors in IDDM. Key words: diet, drugs, environmental factors, infectious agents, insulin-dependent diabetes mellitus. -Environ Health Perspect 1 07(suppl 5):777-781 (1999). http.//ehpnetl.niehs.nih.gov/docs/1999/suppl-5/777-781kraine/abstract.html
Insulin-dependent diabetes mellitus (IDDM)
is an autoimmune disease characterized by monocytic and lymphocytic infiltration of the pancreatic islets. This insulitis results in the gradual destruction of the insulin-secreting [B cells found in the islets and an inability to maintain blood glucose homeostasis. As a result, diabetic patients must control blood glucose levels via exogenous insulin administration and are continually at risk for secondary complications due to fluctuations in blood glucose. Sequelae such as retinopathy, kidney failure, neuropathy, and strokes decrease the diabetic patient's quality of life and can eventually lead to premature death.
Risk for developing IDDM is strongly correlated with the expression of both major histocompatibility complex (MHC) and a number of non-MHC-related genes. However, studies of disease incidence in identical twins reveal only a 30-50% concordance rate (1) . This observation has been interpreted to mean that environmental factors also influence the disease process. A number of other findings also support this notion. For example, individuals who immigrate from a country with low IDDM incidence to one with high incidence adopt the higher disease rate of the new country (2) . Furthermore, northern countries tend to have higher frequencies of IDDM than do southern countries (3) , and the incidence of IDDM is increasing in countries such as Sardinia that have relatively stable genetic backgrounds (4) . There also appears to be an inverse relationship between the development of IDDM and socioeconomic development (5) . Finally, in animal models of IDDM, diet and infection modulate disease susceptibility. (6) . The first concept is based on the observation that some pathogen proteins share sequence or structural homology with self-proteins. For example, the rubella virus capsid protein shares homology with a 52-kD pancreatic islet antigen (7) , and the coxsackie virus P2-C protein shares homology with another pancreatic antigen, glutamic acid decarboxylase (GAD) (8, 9) . The second concept is based on the fact that not all self-reactive T (and B) lymphocytes are deleted from the repertoire. They may a) persist because of low affinity for antigen, b) exist at a very low frequency, or c) react with antigens that are normally sequestered in tissues. In healthy individuals, these autoreactive T lymphocytes normally exist and are not pathogenic. It 
Bystander Activation
In contrast to molecular mimicry, initial tissue injury via bystander activation is not directly antigen specific (10 (14) . The mechanism of high-dose STZ-induced acuteonset IDDM appears to be through damage to the mitochondria of P cells (15) . When STZ is administered in multiple low doses, P-cell necrosis begins by day 5 after the final injection, with blood glucose levels peaking at 1 week or later (after the final injection). This treatment regime is thought to induce a cellmediated immune response, as 5-cell destruction continues after the STZ has been deared from the bloodstream (14) . Therefore, the diabetes induced with multiple doses of STZ may more closely resemble the autoimmune process associated with juvenile-onset IDDM.
A second drug, alloxan, is used to induce IDDM in animal models. Alloxan is toxic to ,B cells for two reasons (16 (29, 30) . Other chronic medications that fit this category include chemotherapeutic agents such as L-asparaginase (31, 32) and IFN-a (33) . Although implicated in the development of IDDM, no direct evidence for the involvement of these latter drugs or for the potential mechanism of action has been reported.
Another common occurrence is that a single drug is implicated in the development of IDDM but only in a small number of cases. For example, pentamidine treatment for Pneumoystis carinii pneumonitis has led to the induction of IDDM following P-cell destruction (34) . Although the involvement of the drug is dear, the low incidence of IDDM and the specific patient population involved also indicate that pentamidine is not a common cause of IDDM. Finally, there are occasional reports of various drugs such as isotretinoin (35) Coxsackie-B4 (CVB) (38, 39) and encephalomyocarditis M (40) are two viruses that have been used to induce IDDM in rodents. Studies in CD-1 mice challenged with a diabetogenic strain of CVB have shown that lymphocytes can destroy acutely infected islet cells, and macrophages are able to lyse chronically infected islets. This results in prolonged hyperglycemia, which reverts to normoglycemia within 6-12 months in most cases (38) . Destruction of islets by macrophages can occur in the absence of detectable viral protein expression (although viral RNA is detectable), suggesting that the development of IDDM is related to prolonged presence of viral RNA in the pancreas. In an earlier study, it was observed that a) CVB infection is mouse strain specific, b) a 3-cell tropic virus is essential, and c) in most cases IDDM is transient (39) . Studies using the encephalomyocarditis virus to induce IDDM are also mouse strain specific and result in a self-limiting disease.
Several groups have developed transgenic mouse models using genes encoding viral antigens and subsequent infection with the corresponding virus in an attempt to induce IDDM [reviewed in von Herrath et al. (41) ]. In these models, expression of the viral antigen gene is localized to 1 cells via the rat insulin promoter. Studies of the immune response after challenge with virus have provided information as to the contribution of T-lymphocyte precursor frequency, thymic negative selection, local antigen concentration, and cytokine milieu in the development of IDDM. All the mice develop IDDM because of an autoimmune process mediated by T lymphocytes, similar to the human juvenile onset disease. Despite the usefulness of these transgenic mouse models, they do not provide evidence for a direct role for viruses in the normal development of IDDM.
The role of bacterial infections in the development of IDDM has been studied through observation of disease incidence in NOD mouse colonies (incidence decreases with bacterial infection) and via administration of bacterial products in adjuvants or immunizations. Administration of complete Freund's adjuvant (CFA) does not prevent insulitis but does prevent overt IDDM in NOD mice. Animals protected from disease have decreased mRNA expression of Thi -type cytokines (42, 43) , increased anti-GAD67 antibodies (GAD is an autoantigen known to be important in the development of IDDM), and Th2 cytokine production (44) . It is thought that Mycobacterium tuberculosis found in CFA is responsible for the protective effect of the adjuvant via immune deviation from a predominandy ThI to a Th2 cytokine response.
A second example of protection from IDDM that implicates a bacterial product involves the bacille Calmette-Guerin (BCG) vaccine, which contains Mycobacterium bovis. BCG protects against IDDM when administered within 3 days after cyclophosphamide treatment (before the onset of insulitis in this model) (45) . BCG is also thought to protect via induction of immune deviation; protected NOD mice exhibit restored anti-GAD67 antibody production and increased IL-4:IFN-y ratios (45) Also, IgG and IgM antibodies specific for CVB and CVB-specific RNA have been found in the sera of newly diagnosed diabetics. Seasonal variation of CVB infection has in some regions paralleled incidence of IDDM. A prospective study found relatively more frequent enteroviral infections during the first trimester of pregnancy in mothers whose children developed IDDM before 3 years of age, with no difference in children developing the disease between 4 and 6 years of age. In the same study, the group of diabetic siblings had a significantly greater number of enterovirus infections than did nondiabetic siblings (48) .
Molecular mimicry, based on homology between the 2C protein of CVB and GAD, has been proposed as one mechanism by which CVB may induce IDDM. Recently, however, Horwitz et al. (49) used three mouse models (NOD, B1O.H2g7, BDC2.5) to elucidate the mechanism by which CVB may induce IDDM. No spontaneous immune response to CVB cross-reactive GAD peptides was observed in NOD or B1O.H2g7 mice infected with CVB, which in turn did not develop IDDM. Both these strains carry the diabetes-associated MHC class II allele I-Ag7, which presents GAD peptides to autoreactive CD4+ T lymphocytes. If CVB induces IDDM via molecular mimicry, one would expect enhanced anti-GAD T-cell reactivity and subsequent development of IDDM in infected mice. BDC2.5 mice that are transgenic for a TCR specific for an unknown pancreatic autoantigen (the majority of the T lymphocytes are specific for this f-cell autoantigen) exhibit an enhanced onset of IDDM following infection with CVB. These results suggest that the CVB infection may induce IDDM via a bystander mechanism.
Recently, retroviral superantigens have been implicated in the development of IDDM. Pancreatic enrichment of the V37 family was observed in two IDDM patients, suggesting superantigen involvement (50) . The superantigen implicated in those two cases was encoded by an endogenous retrovirus related to mouse mammary tumor viruses (51) . The authors propose a two-step model in which systemic polyclonal activation of V17-restricted T cells is triggered by expression of the superantigen in the context of MHC class II. Subsequently, autoreactive T cells of the activated subset may initiate organ-specific destruction of the pancreas. Though the endogenous retrovirus has been identified, the mechanism of tissue destruction and role in disease progression as the initial trigger, final precipitator, or simply as a marker of disease remains unclear.
Summary
Although environmental factors have been implicated in the development of IDDM for years, a unifying influence remains elusive. Because of the polygenic nature of IDDM, such unifying factors may not exist. Specific environmental factors may influence individuals quite differently depending upon the genotype of that individual. Designing prospective studies that take into account genetic background of individuals also remains an obstacle to obtaining accurate data on the role of environmental agents. If these agents do influence the development of IDDM, it must be determined whether they function as initiators of disease, promote progression of an ongoing diabetogenic response, or play multiple roles in the disease process. Clearly, direct identification of environmental factors and their precise role in the disease process will be extremely useful in prevention and treatment of IDDM.
